Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (361-370 of 520) with videos related to

Pageof 52
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 26, 2012
The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technologyKaren A Kurdziel, Joanna H Shih, Andrea B Apolo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 5, 2021
Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapyMarion Eveillard, Neha Korde, Amanda Ciardiello, et al.
Journal of Toxicology and Environmental Health. Part A|April 15, 2020
Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significanceWeixin Wang, Youn K Shim, Joel E Michalek, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
The Journal of Molecular Diagnostics : JMD|October 5, 2015
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease ProgressionWeixin Wang, Meghan Corrigan-Cummins, Emily A Barber, et al.
Radiology|February 27, 2019
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)Christina Messiou, Jens Hillengass, Stefan Delorme, et al.
Blood|March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myelomaNikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma|May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenanceHani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.
Clinical Biochemistry|September 25, 2016
Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral bloodKazunori Murata, Samuel I McCash, Brittany Carroll, et al.
Pageof 52

Showing results (361-370 of 520) with videos related to

Sort By:
Pageof 52
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 26, 2012
The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technologyKaren A Kurdziel, Joanna H Shih, Andrea B Apolo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 5, 2021
Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapyMarion Eveillard, Neha Korde, Amanda Ciardiello, et al.
Journal of Toxicology and Environmental Health. Part A|April 15, 2020
Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significanceWeixin Wang, Youn K Shim, Joel E Michalek, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
The Journal of Molecular Diagnostics : JMD|October 5, 2015
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease ProgressionWeixin Wang, Meghan Corrigan-Cummins, Emily A Barber, et al.
Radiology|February 27, 2019
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)Christina Messiou, Jens Hillengass, Stefan Delorme, et al.
Blood|March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myelomaNikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma|May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenanceHani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.
Clinical Biochemistry|September 25, 2016
Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral bloodKazunori Murata, Samuel I McCash, Brittany Carroll, et al.
Pageof 52